Described herein are pharmaceutical packaging devices which avoid oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medicines, these systems like a syringe using an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with quite minimal permeability to oxygen and comprise